Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3651_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
51 Мб
Скачать
18
https://t.me/medicina_free
F. Halbwachs et al.
Fig. 2.3 Left upper panel: Echocardiography image in parasternal long-axis view showing a mildly dilated LV, with an EDD of 58mm. Right upper panel: Apical four­chamber view showing a mildly dilated LV, with a basal diameter of 58 mm. Left middle panel: Apical four­chamber view showing a non-dilated RV, with a basal diameter of 30 mm. Right middle panel:
Echocardiography image in apical four-chamber view showing a mildly dilated left atrium, with an area of
20.2cm2. Left lower panel: Pulsed Doppler evaluation of the transmitral ow in apical four-chamber view showing normal diastolic function. Right lower panel: Tissue Doppler imaging showing normal LV lling pressure, with an E/e ratio of 4
2 Case 2
https://t.me/medicina_free
19
Fig. 2.4 Exercise stress showing disappearance of PVC during physical effort (upper panel), with reappearance dur- ing the recovery phase (lower panel)
Fig. 2.5 Chest X-ray in posteroanterior view showing a non-enlarged cardiac silhouette, with a normal cardiothoracic index, absence of pleural effusion, and no pulmonary stasis
20
https://t.me/medicina_free
F. Halbwachs et al.
Fig. 2.6 Left panel: Cardiac MRI image (cine SSFP four-chamber view) showing a non-dilated LV and no global or localized dilation of the right ventricle. Right
Figure 2.1 explained. A 12-lead ECG show­ing sinus rhythm with a heart rate of 68 bpm, QRS axis at 0°, absence of LV hypertrophy, absence of ischemia, frequent monomorphic PVC, and normal QT interval. The PVC mor­phology is “notched R” in lead I, “notched R” in leads II, III, and aVF with a LBBB morphology,
panel: Absence of late gadolinium enhancement at the level of the right and left ventricle. No major or minor criteria in favor of arrhythmogenic cardiomyopathy
and a precordial transition in V4, in favor of a RVOT origin. Of note, the PVC QRS transition in precordial leads (V4) takes place later than the QRS transition in sinus rhythm (V3), also an argument in favor of a RVOT origin. The aspect of the QRS complex in lead I—unique “R” wave is in favor of an origin in the posterior part of the
2 Case 2
https://t.me/medicina_free
Fig. 2.7 Signal-averaged ECG showing a QRS duration of 100ms, the amplitude of the last 40ms of the QRS complex of 35μV, and a duration of less than 40μV of 36ms (within normal values)
21
RVOT.The “QS” aspect in lead aVL suggests an origin at less than 3 cm from the pulmonary valve.
Given the presence of a moderate arrhythmia burden and the patient’s occupation, an electro­physiological study in view of a catheter ablation procedure was offered and accepted by the patient. A cardiac CT angiography was per­formed prior to the ablation procedure and subse­quently used for guiding the mapping phase during the EP study.
Electrophysiological Study andRF Catheter Ablation Procedure
The ablation procedure was performed under local anesthesia and conscious sedation. Vascular access was obtained using the modied Seldinger technique, under Doppler ultrasound guidance. A 6F bipolar non-steerable catheter (Viking, Boston Scientic®) was introduced in a 6F 20cm vascu­lar sheath and was subsequently advanced via the right common femoral vein up to the right ven-
tricular apex. A Biosense Webster® SmartTouch SF open-irrigated 3.5mm tip with double curve D/F was used as the roving/ablation catheter, which was introduced in a 9F 20 cm vascular sheath and advanced at the level of the right ven­tricle. The CARTO ® 3 electro-anatomic map­ping system (Biosense Webster, Johnson & Johnson) was used to guide mapping and abla­tion of the accessory pathway.
Ventricular pacing was carried out at twice the diastolic threshold using the EP-4™ Cardiac Stimulator (Abbott®) system. Surface ECG and intracavitary ECGs were recorded by the WorkMate Claris™ System (Abbott®).
Given the 12-lead aspect of the PVC (“notched R” in lead I, “R” in leads II, III, and aVF with a LBBB morphology, and a precordial transition in V4), an origin in the RVOT was suspected. Mapping of the PVC was therefore commenced in the RVOT.
The ECG at the beginning of the electrophysi­ological study is presented in Fig.2.8.
An anatomical map of the RVOT was initially created. Next, an activation map of the RVOT
22
https://t.me/medicina_free
Fig. 2.8 A 12-lead ECG at the beginning of the ablation procedure, showing the presence of frequent isolated PVC, identical to the patient’s clinical PVCs
F. Halbwachs et al.
during the frequent PVCs was created. This showed the presence of an early activation site at the level of the high posterior and lateral RVOT, just below the pulmonary valve, from where the activation of the RVOT spread in a radial manner, suggesting a focal activation pattern (Fig.2.9). At this site, the unipolar electrogram recorded by the roving/ablation catheter had a “QS” aspect.
A pacemap was subsequently created by pac­ing from the distal electrode of the roving/abla­tion catheter at a xed coupling interval of 600ms in several areas of the RVOT, with empha­sis on the area of the earliest activation during the PVCs. The PASO module of the CARTO system was used to compare the resulting 12-lead ECG during local pacing with the morphology of the PVC. A superposed correlation of 98.1% was observed at the earliest activation site of the RVOT, conrming the origin of the PVC at this level (Fig.2.10).
RF energy was applied at this site with a target power of 30W and a target ablation index of 450, with rapid disappearance of the PVC.
After a waiting period of 30min, isoprenaline
was infused, without reappearance of the PVC.
A comparison of the pacemap and the activa-
tion map of the RVOT is presented in Fig.2.11.
There were no complications related to the
procedure.
The ECG at the end of the ablation procedure
is shown in Fig.2.12.
The ECG recorded 24h after the ablation pro-
cedure is shown in Fig.2.13.
The patient was discharged from the hospital
on no antiarrhythmic treatment.
His 24-h Holter ECG performed 10 weeks after the ablation procedure showed the presence of only 30 PVC during 24 h of recording (Fig.2.14).
Answers
Question 1: A.RVOT
Question 2: A.High RVOT and C. poste-
rior RVOT
2 Case 2
https://t.me/medicina_free
23
Fig. 2.9 CARTO image of the right ventricle in PA view cranial 10° showing the superposed cardiac CT angiogra­phy 3D reconstruction image and the anatomical map of the RV acquired with the roving/ablation catheter. The activation map of the RVOT during PVCs is also pre­sented, showing an area of early endocardial activation
(red color at the top of the roving/ablation catheter), pre­ceding the onset of the QRS onset on the surface ECG by 38ms, with a “QS” aspect of the local unipolar electro­gram. The area is situated in the upper lateral posterior part of the RVOT
Fig. 2.10 CARTO image of the right ventricular outow tract (RVOT) in RAO view 140° (right side of the image). Pacemap conrming the origin of the PVC at the site of earliest endocardial activation during PVCs, with a con­cordance of locally generated QRS morphology and spon­taneous PVC morphology of 98.1% (left side of the
image). The roving/ablation catheter was positioned at the site of the earliest endocardial activation. Pacing from this specic site produced a QRS morphology that had a con­cordance of 98.1% with that of the spontaneous PVC, conrming the optimal ablation site
24
https://t.me/medicina_free
F. Halbwachs et al.
Fig. 2.11 Comparison of the pacemap and the activation map of the RVOT after RF ablation of the PVC, showing the anatomical relationship between the earliest activation site on the activation map (right panel) and the best cor­relation site between the locally induced QRS morphol­ogy while pacing from the distal electrode of the roving/
Fig. 2.12 A 12-lead ECG at the end of the ablation procedure showing sinus tachycardia (explained by the IV isoprena­line infusion) with no PVC
ablation catheter and the spontaneous PVC (left and middle panel). Pink and red lesions represent RF lesions. The left panel shows concordance of locally generated QRS morphology and spontaneous PVC morphology of
98.1%
2 Case 2
https://t.me/medicina_free
Fig. 2.13 A 12-lead ECG recorded after the RF ablation procedure, showing sinus rhythm with a heart rate of 71bpm, QRS axis at 0°, no ischemia, and absence of premature ventricular contractions
25
Fig. 2.14 A 24-hour Holter ECG performed 10weeks after the ablation procedure showing the presence of only 30 PVC/24h
26
https://t.me/medicina_free
F. Halbwachs et al.
Commentary
The present case illustrates a catheter ablation procedure of PVC arising from the RVOT in a patient with structurally normal heart. Several aspects merit further comment.
Few, isolated PVCs are common ndings in the adult population, with a prevalence of 40–75% on the 24–48-h Holter ECG monitoring [1]. In the absence of an underlying heart disease and of symptoms, when the arrhythmia burden is low, they do not require treatment. However, when the arrhythmia burden is signicant and they represent more than 10% of the total number of QRS complexes/24h, the risk of developing PVC-induced cardiomyopathy increases signi­cantly [2] (see Case 1).
In the presence of an underlying heart disease, PVCs represent a marker of adverse prognosis [38]. Therefore, in patients with frequent PVCs, a complete cardiology workup, including careful history taking, physical examination, 12-lead ECG, Holter ECG, transthoracic echocardiogra­phy, tests evaluating the presence of coronary artery disease and inducible myocardial isch­emia, and cardiac MRI evaluating the possible presence of several cardiomyopathies (especially arrhythmogenic cardiomyopathy) is appropriate.
Ventricular arrhythmias in the absence of heart disease are called idiopathic. They can pres­ent in a wide range of forms, from isolated PVCs to sustained ventricular tachycardia. They can cause a variety of symptoms, from mild palpita­tions to dyspnea, chest pain, asthenia, fatigue, to near-syncope, and syncope. The most common form of idiopathic ventricular arrhythmias are isolated PVCs. Their most common origin is the RVOT in 70% of cases [9], followed by the LVOT, the aortic cusp region, and the aorto- mitral continuity. Other locations do exist but are less frequent. Treatment options include antiarrhyth­mic medication and catheter ablation. Due to the variable response to antiarrhythmic drugs and to their possible adverse effects when prescribed for long periods of time, catheter ablation has become the preferred treatment option in symp­tomatic patients with a signicant arrhythmia burden and in those with PVC-induced cardio-
myopathy [9]. The origin of the PVC can be iden­tied using the 12-lead ECG [1014]. Several diagnostic clues have been validated, with the purpose of guiding the electrophysiologist when preparing for the catheter ablation procedure.
The characteristics of PVCs originating in the RVOT are (1) LBBB morphology and inferior axis, (2) QRS transition in the precordial leads in V3 or V4, and (3) QRS transition of the PVC in the precordial leads that takes places later than the transition of the QRS complex in sinus rhythm [15]. Several other clues have been described, which can identify a specic region in the RVOT where the PVCs originate. Therefore, the presence of a notch on the top of the R wave in leads II, III, and aVF, together with a late QRS transition in the precordial leads (V4) and a wider QRS duration, characterizes the lateral wall ori­gin. Septal origins are characterized by a nar­rower QRS complex and a transition earlier than V4 [11, 13]. A “QS” aspect in lead aVL is in favor of a high RVOT origin, less than 2cm from the pulmonary valve [16]. The presence of an “R wave” in lead I points to an origin at the level of the posterior RVOT, while the presence of a “Q wave” in lead I usually indicates an origin at the level of the anterior RVOT [17].
In our patient, the 12-lead ECG presented in Fig.2.1 shows the presence of a “QS” aspect in lead aVL and the presence of an “R wave” in lead I, suggesting an origin in the high posterior RVOT, fact conrmed by the activation map per­formed with the CARTO system (Fig.2.9).
Catheter ablation of PVCs can be performed using simple uoroscopy, or it can be guided by an electro-anatomical mapping system, such as the CARTO system. The latter has the advantage of reducing the uoroscopy time and dose [1820].
The success rate of the catheter ablation pro­cedure is high, over 90% in experienced hands [9,
21]. Recurrences are rare and the complication
rate is low. These are mostly related to the vascu­lar access site (hematoma, hemorrhage, pseudoa­neurysm, arteriovenous stula), but cases of pericardial effusion, cardiac tamponade, and pul­monary embolism have also been described [2224].
2 Case 2
https://t.me/medicina_free
27
Given the absence of a structural heart disease in our patient and the good result of the catheter ablation procedure, the long-term prognosis is excellent.
Learning Points
• PVCs arising from the RVOT are char­acterized by LBBB morphology and superior axis, with QRS transition in the precordial leads usually in V3 or V4.
• PVCs originating from the posterior part of the RVOT show an “R” wave in lead I.
• Cather ablation of the PVC guided by an electro-anatomical mapping system is the treatment of choice, given its high success and its low complication rate.
References
1. Ahn MS. Current concepts of premature ventricular contractions. J Lifestyle Med. 2013;3(1):26–33.
2. Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7(7):865–9.
3. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricu­lar arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69(2):250–8.
4. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, etal. Prevalence and prog­nostic signicance of ventricular arrhythmias after acute myocardial infarction in the brinolytic era. GISSI-2 results. Circulation. 1993;87(2):312–22.
5. Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, etal. Signicance of ventricu­lar arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1984;53(7):902–7.
6. Olshausen KV, Stienen U, Schwarz F, Kubler W, Meyer J. Long-term prognostic signicance of ven­tricular arrhythmias in idiopathic dilated cardiomy­opathy. Am J Cardiol. 1988;61(1):146–51.
7. Holmes J, Kubo SH, Cody RJ, Kligeld P.Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiog­raphy. Am J Cardiol. 1985;55(1):146–51.
8. Bikkina M, Larson MG, Levy D.Asymptomatic ven­tricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 1993;22(4):1111–6.
9. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ven­tricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17(11):1601–87.
10. Ludwik B, Deutsch K, Mazij M, Sledz J, Morka A, Labus M, et al. Electrocardiographic algorithms to guide the management strategy of idiopathic outow tract ventricular arrhythmias. Polish Arch Internal Med. 2017;127(11):749–57.
11. Yamada T.Electrocardiographic algorithms to local­ize the origins of idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol. 2012;35(12):1514–5.
12. Ban JE, Park HC, Park JS, Nagamoto Y, Choi JI, Lim HE, et al. Electrocardiographic and electrophysi­ological characteristics of premature ventricular com­plexes associated with left ventricular dysfunction in patients without structural heart disease. Europace. 2013;15(5):735–41.
13. Krittayaphong R, Sriratanasathavorn C, Dumavibhat C, Pumprueg S, Boonyapisit W, Pooranawattanakul S, etal. Electrocardiographic predictors of long-term outcomes after radiofrequency ablation in patients with right-ventricular outow tract tachycardia. Europace. 2006;8(8):601–6.
14. Bala R, Marchlinski FE.Electrocardiographic recog­nition and ablation of outow tract ventricular tachy­cardia. Heart Rhythm. 2007;4(3):366–70.
15. Betensky BP, Park RE, Marchlinski FE, Hutchinson MD, Garcia FC, Dixit S, et al. The V(2) transi­tion ratio: a new electrocardiographic criterion for distinguishing left from right ventricular out­ow tract tachycardia origin. J Am Coll Cardiol. 2011;57(22):2255–62.
16. Joshi S, Wilber DJ.Ablation of idiopathic right ven­tricular outow tract tachycardia: current perspec­tives. J Cardiovasc Electrophysiol. 2005;16(Suppl
1):S52–8.
17. Yamada T, Yoshida N, Litovsky SH, Itoh T, Doppalapudi H, Kay GN. Idiopathic ventricu­lar arrhythmias originating from the infundibular muscles: prevalence, electrocardiographic and elec­trophysiological characteristics, and outcome of catheter ablation. Circ Arrhythm Electrophysiol. 2018;11(3):e005749.
18. Yamagata K, Aldhoon B, Kautzner J. Reduction of uoroscopy time and radiation dosage during catheter ablation for atrial brillation. Arrhythmia Electrophysiol Rev. 2016;5(2):144–9.
19. Knecht S, Sticherling C, Reichlin T, Pavlovic N, Muhl A, Schaer B, etal. Effective reduction of uoroscopy duration by using an advanced electroanatomic­mapping system and a standardized procedural pro­tocol for ablation of atrial brillation: ‘the unleaded study’. Europace. 2015;17(11):1694–9.